| 2026-05-13 |
详情>>
业绩披露：
2026年一季报每股收益0.07美元,归母净利润413.20万美元,同比去年增长4.24%
|
| 2026-05-13 |
财报披露：
美东时间 2026-05-13 盘前发布财报
|
| 2026-03-11 |
详情>>
股本变动：
变动后总股本5768.61万股
变动原因 ▼▲
- 原因：
- From December 31, 2024 to December 31, 2025
Exercise of options into shares units
|
| 2026-03-11 |
详情>>
业绩披露：
2025年年报每股收益0.35美元,归母净利润2019.80万美元,同比去年增长39.66%
|
| 2025-12-08 |
复牌提示：
2025-12-08 06:55:00 停牌，复牌日期 2025-12-08 07:20:00
|
| 2025-11-10 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.29美元,归母净利润1663.60万美元,同比去年增长56.15%
|
| 2025-10-23 |
股东大会：
将于2025-12-10召开股东大会
会议内容 ▼▲
- 1.To re-elect seven directors to serve as members of our Board of Directors until our next annual general meeting of shareholders and until their respective successors are duly elected by the shareholders of the Company.
2.To approve the grant of options to Mr. Amir London, our Chief Executive Officer.
3.To adopt an amended and restated Compensation Policy for Executive Officers and Directors.
4.To approve certain amendments to our Articles of Association, including to permit indemnification and insurance of our directors and officers under the Israeli Securities Law, 1968 and the Israeli Economic Competition Law, 1988.
5.Subject to the approval of Proposal 4, to approve an amendment to the exemption and indemnification undertaking letter issued by the Company to each of its directors and officers to provide for indemnification and insurance to the fullest extent permitted under the Israeli Securities Law, 1968 and Israeli Economic Competition Law, 1988.
6.To ratify and approve the re-appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accountants for the year ending December 31, 2025, and for such additional period until our next annual general meeting of shareholders.
|
| 2025-10-23 |
股东大会：
将于2025-12-10召开股东大会
会议内容 ▼▲
- 1.To re-elect seven directors to serve as members of our Board of Directors until our next annual general meeting of shareholders and until their respective successors are duly elected by the shareholders of the Company.
2.To approve the grant of options to Mr. Amir London, our Chief Executive Officer.
3.To adopt an amended and restated Compensation Policy for Executive Officers and Directors.
4.To approve certain amendments to our Articles of Association, including to permit indemnification and insurance of our directors and officers under the Israeli Securities Law, 1968 and the Israeli Economic Competition Law, 1988.
5.Subject to the approval of Proposal 4, to approve an amendment to the exemption and indemnification undertaking letter issued by the Company to each of its directors and officers to provide for indemnification and insurance to the fullest extent permitted under the Israeli Securities Law, 1968 and Israeli Economic Competition Law, 1988.
6.To ratify and approve the re-appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accountants for the year ending December 31, 2025, and for such additional period until our next annual general meeting of shareholders.
|
| 2025-08-13 |
详情>>
业绩披露：
2025年中报每股收益0.20美元,归母净利润1134.00万美元,同比去年增长66.99%
|
| 2025-05-14 |
详情>>
业绩披露：
2025年一季报每股收益0.07美元,归母净利润396.40万美元,同比去年增长67.61%
|
| 2025-03-05 |
详情>>
业绩披露：
2024年年报每股收益0.25美元,归母净利润1446.20万美元,同比去年增长74.58%
|
| 2024-11-13 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.19美元,归母净利润1065.40万美元,同比去年增长230.25%
|
| 2024-10-21 |
股东大会：
将于2024-12-11召开股东大会
会议内容 ▼▲
- 1.To re-elect seven directors to serve as members of our Board of Directors until our next annual general meeting of shareholders and until their respective successors are duly elected by the shareholders of the Company.
2.To ratify and approve the re-appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accountants for the year ending December 31, 2024, and for such additional period until our next annual general meeting of shareholders.
|
| 2024-10-21 |
股东大会：
将于2024-12-11召开股东大会
会议内容 ▼▲
- 1.To re-elect seven directors to serve as members of our Board of Directors until our next annual general meeting of shareholders and until their respective successors are duly elected by the shareholders of the Company.
2.To ratify and approve the re-appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accountants for the year ending December 31, 2024, and for such additional period until our next annual general meeting of shareholders.
|
| 2024-08-14 |
详情>>
业绩披露：
2024年中报每股收益0.12美元,归母净利润679.10万美元,同比去年增长226266.67%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年一季报每股收益0.04美元,归母净利润236.50万美元,同比去年增长230.74%
|
| 2024-03-06 |
详情>>
业绩披露：
2023年年报每股收益0.17美元,归母净利润828.40万美元,同比去年增长456.92%
|
| 2023-11-13 |
股东大会：
将于2023-12-28召开股东大会
会议内容 ▼▲
- 1.To re-elect seven directors to serve as members of our Board of Directors until our next annual general meeting of shareholders and until their respective successors are duly elected by the shareholders of the Company.
2.To approve an increase in the base salary of Mr. Amir London, our Chief Executive Officer.
3.To ratify and approve the re-appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accountants for the year ending December 31, 2023 and for such additional period until our next annual general meeting of shareholders.
|
| 2023-11-13 |
股东大会：
将于2023-12-28召开股东大会
会议内容 ▼▲
- 1.To re-elect seven directors to serve as members of our Board of Directors until our next annual general meeting of shareholders and until their respective successors are duly elected by the shareholders of the Company.
2.To approve an increase in the base salary of Mr. Amir London, our Chief Executive Officer.
3.To ratify and approve the re-appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accountants for the year ending December 31, 2023 and for such additional period until our next annual general meeting of shareholders.
|
| 2023-07-13 |
股东大会：
将于2023-08-29召开股东大会
会议内容 ▼▲
- 1.To approve the Private Placement, as a result of which FIMI will become a controlling shareholder of the Company (within the meaning of the Israeli Companies Law), in accordance with Section 328 of the Israeli Companies Law and Sections 270(5) and 274 of the Israeli Companies Law.
2. To approve the election of Prof. Benjamin Dekel and Assaf Itshayek as external directors, within the meaning of the Israeli Companies Law, each for an initial three-year term, subject to the approval of Proposal 1 and the closing of the Private Placement.
3. To approve the grant of options to each of Prof. Benjamin Dekel and Assaf Itshayek, subject to their respective election and commencement of service as external directors, within the meaning of the Israeli Companies Law, under and in accordance with Proposal 2.
|
| 2023-07-13 |
股东大会：
将于2023-08-29召开股东大会
会议内容 ▼▲
- 1.To approve the Private Placement, as a result of which FIMI will become a controlling shareholder of the Company (within the meaning of the Israeli Companies Law), in accordance with Section 328 of the Israeli Companies Law and Sections 270(5) and 274 of the Israeli Companies Law.
2. To approve the election of Prof. Benjamin Dekel and Assaf Itshayek as external directors, within the meaning of the Israeli Companies Law, each for an initial three-year term, subject to the approval of Proposal 1 and the closing of the Private Placement.
3. To approve the grant of options to each of Prof. Benjamin Dekel and Assaf Itshayek, subject to their respective election and commencement of service as external directors, within the meaning of the Israeli Companies Law, under and in accordance with Proposal 2.
|
| 2022-11-08 |
股东大会：
将于2022-12-22召开股东大会
会议内容 ▼▲
- 1.To elect nine directors to serve as members of our Board of Directors until our next annual general meeting of shareholders and until their respective successors are duly elected by the shareholders of the Company.
2.To approve the grant of options to each of the director nominees, subject to their respective election as directors under Proposal 1.
3.To approve the grant of options to Mr. Amir London, our Chief Executive Officer.
4.To approve our entering into an indemnification and exculpation agreement with Mr. Uri Botzer, subject to his election as a director under Proposal 1.
5.To amend and readopt our Compensation Policy for Executive Officers and Compensation Policy for Directors.
6.To approve the adoption of the U.S. Taxpayers Appendix to the Kamada Ltd. 2011 Israeli Share Award Plan, for U.S. tax purposes.
7.To ratify and approve the re-appointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accountants for the year ending December 31, 2022 and for such additional period until our next annual general meeting of shareholders.
|
| 2021-11-04 |
股东大会：
将于2021-12-16召开股东大会
会议内容 ▼▲
- 1.election of nine directors to serve as members of our Board of Directors until our next annual general meeting of shareholders and until their successors are duly elected by the shareholders of the Company;
2.subject to the election of Ms. Lilach Payorski to serve as a member of our Board of Directors, approval of our entering into an indemnification and exculpation agreement with her;
3.ratification and approval of the reappointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accountants for the year ending December 31, 2021 and for such additional period until our next annual general meeting of shareholders. In addition, at the Meeting, representatives of our management will be available to review and discuss our consolidated financial statements for the year ended December 31, 2020.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-10-29 |
股东大会：
将于2020-12-10召开股东大会
会议内容 ▼▲
- 1.To elect nine directors to serve as members of our Board of Directors until our next annual general meeting of shareholders and until their successors are duly elected by the shareholders of the Company.
2.Subject to the election of Prof. Ari Shamiss to serve as a member of our Board of Directors, to approve the award of options to Prof. Shamiss and our entering into an indemnification and exculpation agreement with him.
3.To approve an amendment to our Compensation Policy for Executive Officers and Compensation Policy for Directors with respect to the procurement of directors’ and officers’ liability insurance.
4.To ratify and approve the reappointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accountants for the year ending December 31, 2020 and for such additional period until our next annual general meeting of shareholders.
|
| 2020-02-13 |
股东大会：
将于2020-03-25召开股东大会
会议内容 ▼▲
- 1.To approve an amended Compensation Policy for Executive Officers and Compensation Policy for Directors.
2.Subject to the approval of Proposal 1, to approve the grant of options to each of the currently serving directors.
3.To approve amended compensation terms and a one-time award of equity-based compensation, consisting of options and restricted shares, to Mr. Amir London, our Chief Executive Officer.
|
| 2019-11-12 |
股东大会：
将于2019-12-24召开股东大会
会议内容 ▼▲
- 1.To elect nine directors to serve as members of our Board of Directors until our next annual general meeting of shareholders.
2.To approve the grant of options to each of the director nominees (other than Mr. Asaf Frumerman), subject to their election at the Meeting.
3.To approve amended compensation terms and a one-time award of equity-based compensation, consisting of options and restricted shares, to Mr. Amir London, our Chief Executive Officer.
4.To approve an amended Compensation Policy for Executive Officers and Compensation Policy for Directors.
5.To ratify and approve the reappointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accountants for the year ending December 31, 2019 and for such additional period until our next annual general meeting of shareholders.
6.To review and discuss our consolidated financial statements for the year ended December 31, 2018.
|
| 2018-11-07 |
股东大会：
将于2018-12-20召开股东大会
会议内容 ▼▲
- 1.To elect nine directors to serve as members of our Board of Directors until our next annual general meeting of shareholders.
2.Subject to the election of Ms. Efrat Makov to serve as a member of our Board of Directors, to approve our entering into an indemnification and exculpation agreement with Ms. Makov.
3.To approve the grant of options to each of the director nominees (other than Mr. Asaf Frumerman), subject to their election at the Meeting.
4.To approve amended compensation terms and a one-time award of equity-based compensation, consisting of options and restricted shares, to Mr. Amir London, our Chief Executive Officer.
5.To approve an amendment to our Compensation Policy for Executive Officers and Directors, with respect to the maximum side “A” directors’ and officers’ liability coverage.
6.To ratify and approve the reappointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accountants for the year ending December 31, 2018 and for such additional period until our next annual general meeting.
7.To review and discuss our consolidated financial statements for the year ended December 31, 2017.
|
| 2017-10-26 |
股东大会：
将于2017-11-30召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve as members of our Board of Directors until our next annual general meeting of shareholders.
2.Subject to the election of Ms. Gwen A. Melincoff to serve as a member of our Board of Directors, to approve our entering into an indemnification and exculpation agreement with Ms. Melincoff.
3.Subject to the approval of Proposal 1, to approve the grant of options to each of our directors.
4.To approve the grant of options and restricted shares to Mr. Amir London, our Chief Executive Officer.
5.To approve an amendment to our Compensation Policy for Executive Officers and Directors, with respect to the maximum aggregate annual premium payable for directors' and officers' liability insurance.
6.To ratify and approve the reappointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accountants for the year ending December 31, 2017 and for such additional period until our next annual general meeting.
7.To review and discuss our consolidated financial statements for the year ended December 31, 2016.
|
| 2016-07-20 |
股东大会：
将于2016-08-30召开股东大会
会议内容 ▼▲
- 1. To elect five directors to serve as members of our Board of Directors until our next annual general meeting of shareholders and in accordance with our Articles of Association.
2. To elect Mr. Avraham Berger as an outside director, within the meaning of the Israeli Companies Law, 1999 (the “Israeli Companies Law”), for an initial three-year term.
3. To ratify and approve our entering into an indemnification and exculpation agreement with each of Dr. Michael Berelowitz and Mr. Saadia Ozeri and, subject to approval of Proposal 2, to approve our entering into an indemnification and exculpation agreement with Mr. Avraham Berger.
4. To approve the grant of options to each of our directors, other than the outside directors.
5. Subject to approval of Proposals 2 and 4, to approve the grant of options to our outside directors.
6. To approve amended compensation and the grant of options and, subject to approval of Proposal 8, restricted shares to Mr. Amir London, our Chief Executive Officer.
7. To approve certain amendments to our Articles of Association related to the service of outside directors on our Board of Directors and to approve and adopt an English language version of the amended Articles of Association as our governing Articles of Association.
8. To approve an amended and restated Compensation Policy for Executive Officers and Directors.
9. To ratify and approve the reappointment of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as our independent registered public accountants for the year ending December 31, 2016 and for such additional period until our next annual general meeting.
10. To review and discuss our consolidated financial statements for the year ended December 31, 2015.
|